First Trust Amex Biotech Index Fund (FBT): Price and Financial Metrics ETF
FBT Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $152.28 | 52-week high | $161.41 |
Prev. close | $153.44 | 52-week low | $130.27 |
Day low | $152.22 | Volume | 16,800 |
Day high | $153.33 | Avg. volume | 27,511 |
50-day MA | $149.71 | Dividend yield | N/A |
200-day MA | $148.69 |
FBT Stock Price Chart Interactive Chart >
First Trust Amex Biotech Index Fund (FBT) ETF Bio
The investment objective of the First Trust Amex Biotech Index Fund ETF seeks to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
FBT ETF Info
Issuer | First Trust Portfolios |
Expense Ratio | 0.55% |
Underlying Index | NYSE Arca Biotechnology Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 1.14B |
Net Asset Value (NAV) | $153.68 |
Options? | Yes |
Total Holdings | 32 |
FBT Top Holdings
Symbol | Company | % of Total |
MRNA | Moderna Inc. | 3.9% |
MTD | Mettler-Toledo International Inc. | 3.83% |
AMGN | Amgen Inc. | 3.8% |
BIIB | Biogen Inc. | 3.78% |
HALO | Halozyme Therapeutics Inc. | 3.77% |
CORT | Corcept Therapeutics Incorporated | 3.76% |
UTHR | United Therapeutics Corporation | 3.73% |
BGNE | BeiGene Ltd. (ADR) | 3.71% |
NTRA | Natera Inc. | 3.61% |
WAT | Waters Corporation | 3.57% |
FBT Price Returns
1-mo | 7.60% |
3-mo | 2.07% |
6-mo | 8.63% |
1-year | -3.72% |
3-year | -3.64% |
5-year | 18.62% |
YTD | -3.65% |
2023 | 2.55% |
2022 | -4.83% |
2021 | -2.26% |
2020 | 12.96% |
2019 | 19.74% |